CONMED Corp. Stock
CONMED Corp. Stock
CONMED Corp. gained 0.630% compared to yesterday.
Our community is currently high on CONMED Corp. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 53 € shows a very positive potential of 66.67% compared to the current price of 31.8 € for CONMED Corp..
Pros and Cons of CONMED Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | 0.630% | -3.636% | 1.274% | -27.397% | -9.143% | -69.714% | -71.091% |
| Bio-Rad Labs Inc. A | -6.450% | -2.591% | 5.388% | 9.463% | -6.708% | -42.550% | -54.604% |
| Glaukos Corp | -0.970% | - | - | - | - | - | - |
| Integra LifeSciences Holdings Corp | 0.000% | -6.915% | 7.362% | -40.476% | -17.453% | -83.491% | -85.772% |
Comments
CONMED (CNMD) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Show more
Ratings data for CNMD provided by MarketBeat
CONMED (CNMD) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for CNMD provided by MarketBeat
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat